| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.639 | 33.250 | 31.737 | 25.452 | 29.670 | 25.524 | 14.229 | 21.884 | 19.599 | 19.658 |
| Total Income - EUR | 41.639 | 34.603 | 31.737 | 25.734 | 29.670 | 25.524 | 14.229 | 21.884 | 19.599 | 19.658 |
| Total Expenses - EUR | 22.199 | 20.815 | 15.197 | 17.631 | 15.989 | 14.740 | 17.739 | 11.695 | 18.158 | 24.471 |
| Gross Profit/Loss - EUR | 19.440 | 13.787 | 16.541 | 8.103 | 13.681 | 10.784 | -3.509 | 10.189 | 1.441 | -4.813 |
| Net Profit/Loss - EUR | 18.191 | 13.095 | 16.223 | 7.846 | 13.384 | 10.528 | -3.936 | 9.533 | 1.245 | -5.403 |
| Employees | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Profilaxia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54 | 0 | 0 | 3.055 | 3.512 | 3.445 | 3.369 | 458 | 1.027 | 583 |
| Current Assets | 38.366 | 16.198 | 17.018 | 21.482 | 13.100 | 22.964 | 11.012 | 18.200 | 10.670 | 5.184 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.428 | 2.530 | 3.040 | 1.850 | 1.653 | 3.013 | 3.897 | 2.039 | 2.202 | 1.947 |
| Cash | 36.938 | 13.668 | 13.979 | 19.632 | 11.447 | 19.951 | 7.115 | 16.160 | 8.468 | 3.237 |
| Shareholders Funds | 36.379 | 13.140 | 16.442 | 23.986 | 13.595 | 18.345 | 14.002 | 9.736 | 10.951 | -2.474 |
| Social Capital | 45 | 45 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 2.042 | 3.058 | 576 | 551 | 3.018 | 8.064 | 379 | 8.922 | 746 | 8.241 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Profilaxia Srl